Literature DB >> 23970478

The p90 RSK family members: common functions and isoform specificity.

Romain Lara1, Michael J Seckl, Olivier E Pardo.   

Abstract

The p90 ribosomal S6 kinases (RSK) are implicated in various cellular processes, including cell proliferation, survival, migration, and invasion. In cancer, RSKs modulate cell transformation, tumorigenesis, and metastasis. Indeed, changes in the expression of RSK isoforms have been reported in several malignancies, including breast, prostate, and lung cancers. Four RSK isoforms have been identified in humans on the basis of their high degree of sequence homology. Although this similarity suggests some functional redundancy between these proteins, an increasing body of evidence supports the existence of isoform-based specificity among RSKs in mediating particular cellular processes. This review briefly presents the similarities between RSK family members before focusing on the specific function of each of the isoforms and their involvement in cancer progression. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23970478     DOI: 10.1158/0008-5472.CAN-12-4448

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.

Authors:  Stephane Esnault; Elizabeth A B Kelly; Zhong-Jian Shen; Mats W Johansson; James S Malter; Nizar N Jarjour
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

2.  Rheumatoid arthritis. The two faces of Rsk2 in hyperplastic disease.

Authors:  Jane Falconer; Christopher D Buckley
Journal:  Nat Rev Rheumatol       Date:  2015-01-27       Impact factor: 20.543

3.  Clinicopathological significance of ribosomal protein S6 kinase A6 in lung squamous cell carcinoma: an immunohistochemical and RNA-seq study.

Authors:  Ye-Ying Fang; Fu-Chao Ma; Xu-Li Gan; Wen-Qi Luo; Rong-Quan He; Hui-Min Xie; Shi-Yu Li; Gang Chen; Dan-Ming Wei; Xiao-Hua Hu
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.

Authors:  Guoyu Yu; Yu-Chen Lee; Chien-Jui Cheng; Chuan-Fen Wu; Jian H Song; Gary E Gallick; Li-Yuan Yu-Lee; Jian Kuang; Sue-Hwa Lin
Journal:  Mol Cancer Res       Date:  2014-09-04       Impact factor: 5.852

5.  Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin.

Authors:  Nabeel Abdulrahman; Maiy Jaballah; Noufira Poomakkoth; Sadaf Riaz; Somaia Abdelaziz; Aya Issa; Fatima Mraiche
Journal:  Mol Cell Biochem       Date:  2016-05-28       Impact factor: 3.396

6.  RSK1 activation promotes invasion in nodular melanoma.

Authors:  Amel Salhi; Joshua A Farhadian; Keith M Giles; Eleazar Vega-Saenz de Miera; Ines P Silva; Caitlin Bourque; Karen Yeh; Sagar Chhangawala; Jinhua Wang; Fei Ye; David Y Zhang; Eva Hernando-Monge; Yariv Houvras; Iman Osman
Journal:  Am J Pathol       Date:  2015-01-08       Impact factor: 4.307

7.  Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells.

Authors:  Lan Deng; Ling Jiang; Xianghua Lin; Kuo-Fu Tseng; Zhigang Lu; Xiuju Wang
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

8.  β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.

Authors:  Jia Ma; Yanwei Lu; Sheng Zhang; Yan Li; Jing Huang; Zhongyuan Yin; Jinghua Ren; Kai Huang; Li Liu; Kunyu Yang; Gang Wu; Shuangbing Xu
Journal:  Cell Death Differ       Date:  2018-02-02       Impact factor: 15.828

9.  Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice.

Authors:  Kirsty Sawicka; Alexander Pyronneau; Miranda Chao; Michael V L Bennett; R Suzanne Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

10.  Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.

Authors:  Rui Wang; Lijuan Xia; Janice Gabrilove; Samuel Waxman; Yongkui Jing
Journal:  Clin Cancer Res       Date:  2015-10-12       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.